In the past week, VTAK stock has gone down by -28.58%, with a monthly gain of 17.39% and a quarterly plunge of -37.46%. The volatility ratio for the week is 4.11%, and the volatility levels for the last 30 days are 25.08% for Catheter Precision Inc The simple moving average for the past 20 days is -9.09% for VTAK’s stock, with a -36.26% simple moving average for the past 200 days.
Is It Worth Investing in Catheter Precision Inc (AMEX: VTAK) Right Now?
VTAK has 36-month beta value of -0.83. Analysts have mixed views on the stock, with 1 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for VTAK is 10.32M, and currently, short sellers hold a 5.16% ratio of that float. The average trading volume of VTAK on June 24, 2025 was 13.61M shares.
VTAK) stock’s latest price update
Catheter Precision Inc (AMEX: VTAK)’s stock price has increased by 1351099 compared to its previous closing price of 0.27. However, the company has seen a -28.58% decrease in its stock price over the last five trading sessions. globenewswire.com reported 2025-06-12 that FORT MILL, S.C., June 12, 2025 (GLOBE NEWSWIRE) — Catheter Precision, Inc. (NYSE American: VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, is issuing this press release in response to recent increases in trading activity in its common stock. The Company is not aware of any information related to the Company or its operations that it would have expected to cause increased market activity. The Company continues to pursue its strategic plans as previously disclosed, including its ongoing efforts to secure financing to meet its liquidity needs.
Analysts’ Opinion of VTAK
Many brokerage firms have already submitted their reports for VTAK stocks, with Piper Jaffray repeating the rating for VTAK by listing it as a “Neutral.” The predicted price for VTAK in the upcoming period, according to Piper Jaffray is $1.50 based on the research report published on August 13, 2019 of the previous year 2019.
Maxim Group, on the other hand, stated in their research note that they expect to see VTAK reach a price target of $23. The rating they have provided for VTAK stocks is “Buy” according to the report published on November 02nd, 2018.
VTAK Trading at -12.84% from the 50-Day Moving Average
After a stumble in the market that brought VTAK to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -97.07% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at VTAK starting from COLOMBATTO MARTIN J, who sale 3 shares at the price of $0.40 back on Jan 29 ’25. After this action, COLOMBATTO MARTIN J now owns 0 shares of Catheter Precision Inc, valued at $1 using the latest closing price.
Stock Fundamentals for VTAK
Current profitability levels for the company are sitting at:
- -25.35 for the present operating margin
- 0.9 for the gross margin
The net margin for Catheter Precision Inc stands at -37.45. The total capital return value is set at -0.59. Equity return is now at value -136.26, with -68.20 for asset returns.
Based on Catheter Precision Inc (VTAK), the company’s capital structure generated 0.18 points at debt to capital in total, while cash flow to debt ratio is standing at -5.73. The debt to equity ratio resting at 0.21. The interest coverage ratio of the stock is -358.56.
Currently, EBITDA for the company is -11.3 million with net debt to EBITDA at -0.11. When we switch over and look at the enterprise to sales, we see a ratio of 8.99. The receivables turnover for the company is 5.66for trailing twelve months and the total asset turnover is 0.02. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.21.
Conclusion
To put it simply, Catheter Precision Inc (VTAK) has had a bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
